PFE vs SMCI: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and Super Micro Computer, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
VS
Super Micro Computer, Inc. · Technology
$30.66
+45.0% upside to fair value
Grade B
QuantHub Verdict
SMCI has more upside to fair value (+45.0%). SMCI trades at a lower forward P/E (14.7x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric PFE SMCI
Current Price $25.22 $30.66
Fair Value Estimate $25.92 $44.46
Upside to Fair Value +2.8% +45.0%
Market Cap $143.7B $18.4B
Forward P/E 19.2x 14.7x
EV / EBITDA 12.3x 13.6x
Price / Sales 2.3x 0.6x
Price / FCF 15.2x -2.7x
Revenue Growth YoY +5.4% +122.7%
Gross Margin 69.3% 8.4%
Operating Margin 23.4% 4.5%
Return on Equity 8.4% 18.2%
Dividend Yield 0% 0%
FCF Yield 6.6%
Analyst Consensus Hold Hold
Investment Thesis
PFE — Pfizer Inc.
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
SMCI — Super Micro Computer, Inc.
Super Micro Computer, Inc. is a technology company specializing in server and storage systems, with a strong focus on AI infrastructure. The business quality is medium due to its founder-led management with over 30 years of tenure, a widening moat driven by systems engineering and close partnerships with Nvidia, and rapid revenue growth of 122.7% in the most recent quarter. However, the company f…
Accumulation Zones
Metric PFE SMCI
Zone Low $19.44 $33.34
Zone High $22.03 $37.79
In Buy Zone? No Yes
← PFE Research    SMCI Research →    All Research